Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound. The study will assess the safety and effectiveness of atogepant for the preventive treatment of migraine in Korean adult patients with chronic migraine or episodic migraine under routine clinical practice. Atogepant is an approved drug for preventive treatment of migraine in adults. Approximately 3000 adult participants who are prescribed atogepant by their doctors will be enrolled in this study in Korea. Participants will receive atogepant oral tablets as prescribed by their physician. Participants will be followed for up to week 12. There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.
Study Type
OBSERVATIONAL
Enrollment
3,000
Oral Tablet
On Hospital /ID# 285157
Busan, Busan Gwang Yeogsi, South Korea
RECRUITINGRyu Sang Hyo Neurosurgery Clinic /ID# 284804
Busan, Busan Gwang Yeogsi, South Korea
RECRUITINGDong-A University Medical Center /ID# 275321
Busan, Busan Gwang Yeogsi, South Korea
RECRUITINGChungnam National University Hospital /ID# 284724
Daejeon, Daejeon Gwang Yeogsi, South Korea
Percentage (%) of participants who reported serious adverse event (SAE)/drug reaction (SADR)
Percentage (%) of participants who reported serious adverse event (SAE)/drug reaction (SADR)
Time frame: Up to approximately 16 Weeks
Percentage (%) of participants who reported unexpected (not reflected in the latest approved label) adverse event (AE)/drug reaction (ADR)
Percentage (%) of participants who reported unexpected (not reflected in the latest approved label) adverse event (AE)/drug reaction (ADR)
Time frame: Up to approximately 16 Weeks
Percentage (%) of participants who reported known (labeled) ADR
Percentage (%) of participants who reported known (labeled) ADR
Time frame: Up to approximately 16 Weeks
Percentage (%) of participants who reported non-serious AE/ADR
Percentage (%) of participants who reported non-serious AE/ADR
Time frame: Up to approximately 16 Weeks
Percentage (%) of participants who reported the events related to important potential risks and missing information defined in the Risk Management Plan (RMP)
Percentage (%) of participants who reported the events related to important potential risks and missing information defined in the RMP
Time frame: Up to approximately 16 Weeks
Percentage (%) of participants with AE: overall summary
Percentage (%) of participants with AE: overall summary
Time frame: Up to approximately 16 Weeks
Percentage (%) of participants with common (>=5%) AE
Percentage (%) of participants with common (\>=5%) AE
Time frame: Up to approximately 16 Weeks
Percentage (%) of participants with AE leading to treatment discontinuation
Percentage (%) of participants with AE leading to treatment discontinuation
Time frame: Up to approximately 16 Weeks
Percentage (%) of participants who reported treatment-related AE per the investigator causality assessment
Percentage (%) of participants who reported treatment-related AE per the investigator causality assessment
Time frame: Up to approximately 16 Weeks
Percentage (%) of participants who reported treatment-related serious AE per the investigator causality assessment
Percentage (%) of participants who reported treatment-related serious AE per the investigator causality assessment
Time frame: Up to approximately 16 Weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Chuncheon Sacred Heart Hospital /ID# 275315
Gangwon-do, Gang Weondo, South Korea
RECRUITINGChonnam National University Hospital /ID# 275318
Gwangju, Gwangju Gwang Yeogsi, South Korea
RECRUITINGKorea University Ansan Hospital /ID# 284725
Ansan-si, Gyeonggido, South Korea
RECRUITINGInje University - Ilsan Paik Hospital /ID# 280738
Goyang, Gyeonggido, South Korea
RECRUITINGNational Health Insurance Corporation Ilsan Hospital /ID# 285128
Goyang-si, Gyeonggido, South Korea
RECRUITINGHallym University Dongtan Sacred Heart Hospital /ID# 273581
Hwaseong, Gyeonggido, South Korea
RECRUITING...and 26 more locations